Lamotrigine Tablet, Orally Disintegrating
Product Images NDC 0115-9942

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 0115-9942). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Of New York Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Lamotrigine Orally Disintegrating Tablets Patheon 1)

Chemical structure diagram of lamotrigine showing its chlorine-substituted phenyl ring and triazine ring with attached amino groups.*

FDA Label Image

Figure 1 Kaplan-meier Estimation Of Cumulative Proportion Of Patients With Mood Episode (trial 1) (Lamotrigine Orally Disintegrating Tablets Patheon 2)

A Kaplan-Meier failure probability plot showing failure probability (%) on the y-axis versus weeks (0-100) on the x-axis. Two curves compare failure probability over time for Lamotrigine and placebo groups, with censored data points marked. Lamotrigine group shows lower failure probability compared to placebo throughout the study period.*

FDA Label Image

Figure 2 Kaplan-meier Estimation Of Cumulative Proportion Of Patients With Mood Episode (trial 2) (Lamotrigine Orally Disintegrating Tablets Patheon 3)

A Kaplan-Meier failure probability curve comparing Lamotrigine and placebo over weeks with failure probability (%) on the y-axis and weeks on the x-axis. The graph includes censored data points and shows separate lines for Lamotrigine and placebo treatments.*

FDA Label Image

Tablet_drawing (Lamotrigine Orally Disintegrating Tablets Patheon 4)

This panel describes Lamotrigine orally disintegrating tablets available in 25 mg, 50 mg, 100 mg, and 200 mg strengths. Each is an off-white to white circular tablet debossed on one side with unique codes: IX526 (25 mg), IX527 (50 mg), IX528 (100 mg), and IX529 (200 mg), with the other side plain.*

FDA Label Image

Lamotrigine-25mg-carton (Lamotrigine Orally Disintegrating Tablets Patheon 5)

Packaging label for Lamotrigine Orally Disintegrating Tablets 25 mg by Amneal Pharmaceuticals of New York LLC. The label indicates a package of 30 tablets, divided into 2 blisters of 15 tablets each. The label warns phenylketonurics about phenylalanine content and includes storage instructions and directions to dispense with a Medication Guide. Manufacturing details are also included, and the label features illustrations showing proper tablet removal and administration without liquid.*

FDA Label Image

Lamotrigine_50mg_carton (Lamotrigine Orally Disintegrating Tablets Patheon 6)

Lamotrigine 50 mg orally disintegrating tablets packaging label from Amneal Pharmaceuticals of New York LLC. The label states a package size of 30 tablets, divided into 2 blisters of 15 tablets each. It includes warnings, storage instructions, a phenylalanine content note, and images demonstrating tablet administration. Manufactured by Patheon Inc. in Canada.*

FDA Label Image

Lamotrigine_100mg_carton (Lamotrigine Orally Disintegrating Tablets Patheon 7)

Packaging label for Lamotrigine 100 mg orally disintegrating tablets by Amneal Pharmaceuticals of New York LLC. The carton contains 30 tablets, divided into 3 blisters of 10 tablets each. The label includes storage instructions, manufacturer details, and directions for use, along with a caution to verify product dispensed and a note for phenylketonurics. Illustrations show how to use the orally disintegrating tablets.*

FDA Label Image

Lamotrigine_200mg_carton (Lamotrigine Orally Disintegrating Tablets Patheon 8)

Packaging label for Lamotrigine 200 mg orally disintegrating tablets by Amneal Pharmaceuticals, containing 30 tablets in 3 blisters of 10 tablets each. The label includes usage directions, caution statements for pharmacists and phenylketonurics, storage instructions, and manufacturer information for Patheon Inc. and Amneal Pharmaceuticals LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.